Drug Testing Locations - Burlington, MA

Drug Testing in Burlington, MA

Burlington, Massachusetts Statistics

In Burlington, MA, Middlesex County saw a 12% increase in opioid-related overdose deaths from 2018 to 2020.

Burlington, MA reported 34 opioid overdose deaths in 2019, marking a significant issue within Middlesex County.

Middlesex County, containing Burlington, had 1,562 opioid-related emergency department visits in 2020.

In 2020, Middlesex County had the highest number of opioid-related overdose deaths in Massachusetts at 340.

Burlington, MA, reported a rise in fentanyl-related overdose cases by 18% from 2019 to 2020.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Burlington, MA & Drug Testing Policies

Many employers in Burlington, MA, conduct pre-employment screenings and random drug tests as a part of their company policies, ensuring a drug-free workplace.

These drug testing policies align with guidelines provided by the Massachusetts Department of Labor Standards DLS.

Companies aim to maintain productivity and safety for all employees through strict drug testing standards, which are periodically reviewed and updated.

Government Efforts with Drug Problems in Burlington, MA

The Burlington Drug Task Force partners with local law enforcement to tackle drug issues in Middlesex County. They work on educational programs and initiatives to reduce drug abuse.

State-level efforts involve the Massachusetts Department of Public Health MDPH, providing resources and services related to prevention and recovery.

Local Drug Busts & News in Burlington, MA

In recent months, Burlington, MA has seen a heightened focus on combating drug-related activities. Local police have amplified their efforts in collaboration with neighboring towns to address the growing concern of illegal drug distribution. The increase in patrols and community engagement events highlights the proactive approach of law enforcement to ensure the safety and well-being of residents.

One of the key strategies employed by Burlington police has been the establishment of a task force dedicated to identifying and dismantling drug networks. This initiative has led to numerous arrests and the confiscation of substantial quantities of narcotics. The task force works closely with public health officials to address the root causes of drug abuse, aiming for a multifaceted solution to the issue.

In addition to enforcement, Burlington has prioritized prevention and education within the community. Schools and local organizations host workshops and seminars focused on raising awareness about the dangers of drug abuse. These educational programs aim to empower residents, particularly the youth, with knowledge and resources to resist peer pressure and make informed decisions.

Recently, a series of successful undercover operations led to the shutdown of a significant drug distribution ring operating within the region. The collaborative efforts between Burlington law enforcement and federal agencies played a crucial role in the investigation, showcasing the importance of inter-agency cooperation in addressing drug-related crimes.

Community feedback has been overwhelmingly supportive of the town's initiatives to curb drug-related issues. Residents express a sense of relief and optimism, acknowledging the positive impact of the intensified efforts. The ongoing dialogue between Burlington officials and community members is vital in adapting strategies to effectively tackle the ever-evolving challenges posed by drug-related activities.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Burlington, MA. Trusted by employers nationwide for accurate results and exceptional service.

Massachusetts DOT/Non DOT Physicals

Massachusetts Vision Tests

Massachusetts Audiograms

Massachusetts Respirator Fit Tests

Massachusetts Lift Tests

Massachusetts Background Checks

Clinical Testing Services

TB Testing in MA

Diabetes Testing in MA

Infectious Disease Testing in MA

Sickle Cell Anemia Testing in MA

Women/Men's Health Testing in MA

Resources & Citations

Massachusetts o-drug Response

Boston Medical Center Substance Use Disorder

Learn to Cope

Northwest Middlesex Family Institute

Middlesex District Attorney

Massachusetts Department of Public Health

Recovery.org

Hello Life

Drug Testing Near Burlington, MA

River Pines, MA

Stoneham, MA

Winchester, MA

Billerica, MA

Reading, MA

Lexington, MA

North Wilmington, MA

Silver Lake, MA

Nutting Lake, MA

Woburn, MA

Wilmington, MA

Pinehurst, MA

Frequently Asked Questions

Customer Reviews